Top compounds associated with response to MED12L


Feature Type Standardized
Nominal ANOVA
mRNA WH-4-023 GDSC1000 pan-cancer AAC -0.024 0.6
mRNA Axitinib GDSC1000 pan-cancer AAC -0.018 0.6
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.6
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.6
mRNA MGCD-265 CTRPv2 pan-cancer AAC 0.016 0.6
mRNA tamatinib CTRPv2 pan-cancer AAC -0.017 0.6
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.017 0.6
mRNA FR-180204 GDSC1000 pan-cancer AAC 0.016 0.7
mRNA Irinotecan gCSI pan-cancer AAC 0.024 0.7
mRNA thapsigargin gCSI pan-cancer AAC 0.026 0.7
Download CSV